Advanced Search

 

Study ID Status Title Patient Level Data
SAS40023 Completed A multi-centre, prospective study of Viani 50/250µg twice daily via Diskus in patients with mild to moderate asthma Viani and Diskus are registered trademarks of the GlaxoSmithKline group of companies.
SAS40024 Completed A Randomized, Double-Blind, Parallel-Group Study Evaluating the Protective Effects of the Fluticasone Propionate/Salmeterol Combination Product (FSC, 100/50mcg BID via DISKUS) Against Bronchospasms Induced by Activity as Measured by Exercise Challenge Testing in Adolescent and Adult Subjects who Require Chronic Inhaled Corticosteroid Therapy for the Treatment of Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
SAS40025 Completed A Randomized, Double-Blind, Parallel-Group Study Evaluating the Protective Effects of the Fluticasone Propionate/Salmeterol Combination Product (FSC 250/50mcg BID via DISKUS) Against Bronchospasms Induced by Activity as Measured by Exercise Challenge Testing in Adolescent and Adult Subjects who Require Chronic Inhaled Corticosteroid Therapy for the Treatment of Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
SAS40026 Completed A Randomized, Double-Blind, Parallel Group, Comparative Trial of Salmeterol/Fluticasone Propionate Combination Product 50/100mcg twice daily Diskus Versus Fluticasone Propinate 250 mcg twice daily Diskus in Adolescents and Adults With Moderate To Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
SAS40027 Completed A Randomized, Double-Blind, Parallel Group, Comparative Trial of Salmeterol/Fluticasone Propionate Combination Product 50/100mcg twice daily Diskus Fluticasone Propinate 250 mcg twice daily Diskus In Adolescents and Adults With Moderate to Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
SAS40028 Completed An Open-Label, 12-Week Study to Evaluate the Effects of a Corticosteroid-Sparing Dose of Salmeterol/Fluticasone Propionate Combination Product 50/100mcg twice daily Via the DISKUS Inhaler on Airway Inflammation, Airway Remodeling, and Bronchial Hyperresponsiveness in Adults with Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
SAS40030 Completed A study to investigate switching from usual therapy to the salmeterol/ fluticasone (50/500 mcg) combination Diskus, followed by a reduction of inhaled steroid dosage in patients with moderate to severe asthma
SAS40032 Completed A randomised, parallel-group study of Viani (Salmeterol 50 mcg plus Fluticasone 250 mcg b.i.d.) inhaled from the Diskus® inhaler compared to Budesonide (800-1600 mcg) inhaled from Turbuhaler® plus a long-acting inhaled beta-2-agonist, in subjects with asthma
SAS40036 Completed A multicenter, randomized, double-blind, double-dummy, parallel group, 16-week comparison of asthma control in adolescent and adults receiving either fluticasone propionate/salmeterol Diskus combination product 100/50mcg twice daily, fluticasone propionate Diskus 100mcg twice daily, salmeterol xinafoate 50mcg twice daily, or oral montelukast 10mg every day Study Listed on ClinicalStudyDataRequest.com
SAS40037 Completed A multicenter, randomized, double-blind, double-dummy, parallel group, 16-week comparison of asthma control in adolescents and adults receiving either fluticasone propionate/salmeterol Diskus combination product 100/50mcg twice daily, fluticasone propionate Diskus 100mcg twice daily, salmeterol xinafoate 50mcg twice daily, or oral montelukast 10mg every day Study Listed on ClinicalStudyDataRequest.com
SAS40039 Completed Fluticasone propionate 250 µg plus salmeterol 50 µg (Seretide 50/250 µg bd) combined in a single inhaler (Diskus) in symptomatic patients with mild to moderate asthma previously not treated by maintenance therapy with inhaled corticosteroids and/or long acting beta agonists in adults and childre ...
SAS40066 Completed A Randomized, Open Label, Pilot Crossover Trial, Assessing Patient Preference for Efficacy of Advair Diskus 100/50 (Fluticasone Propionate 100mcg and Salmeterol 50mcg Combination Product 100/50mcg twice daily) and Singulair (Montelukast 10mg every day) in Subjects>15 years of Age with Persistent Asthma Study Listed on ClinicalStudyDataRequest.com
SAS40067 Completed Gaining asthma control with Seretide 50/500 in patients with moderate to severe persistent asthma in general practice.
SAS40068 Completed A 24 week, multicentre, randomized, double-blind, parallel group trial to compare the efficacy and tolerability of salmeterol/fluticasone propionate (ADVAIR) DISKUS inhalation ...
SB020001 Completed A Four-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multi-Center Study of VENTOLIN™ (albuterol) HFA MDI delivered with facemask and two different holding chambers in Subjects aged 24 to <48 months with asthma symptoms (i.e. wheeze, cough, dyspnea or chest tightness) or consistent with asthma or obstructive airway disease or bronchospasm. Study Listed on ClinicalStudyDataRequest.com
SB030001 Completed A Four-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multi-Center Study of VENTOLIN™ HFA MDI delivered TID with facemask and valved holding chamber Aerochamber Plus in subjects birth to <24 months in age with symptoms of bronchospasm (i.e. wheeze, cough, dyspnea or chest tightness) consistent with obstructive airways disease. Study Listed on ClinicalStudyDataRequest.com
SB030002 Completed A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively with a valved holding chamber and an attached facemask in subjects between birth to 23 months of age with acute wheezing due to obstructive airways disease Study Listed on ClinicalStudyDataRequest.com
SB030003 Completed An Open-Label, Multi-Center Study to Evaluate the Performance and Patient Satisfaction of Albuterol HFA with Counter in Asthma or COPD Subjects at Least 4 Years of Age. Study Listed on ClinicalStudyDataRequest.com
SB29060.833 Completed An open label study assessing Paxil CR (paroxetine CR) in patients with major depressive disorder who discontinued treatment with selective serotonin reuptake inhibitors or a selective serotonin/norepinephrine reuptake inhibitor due to intolerability
SB-462795/008 Completed An open-label, two-period, fixed sequence, randomized, parallel group, interaction study to determine the effects of repeat doses of relacatib on the metabolism of acetaminophen, ibuprofen and atorvastatin in healthy postmenopausal female subjects
SB-480848/026 Completed An international, multicenter, randomized, placebo controlled, parallel-group, 1 year treatment, integrated biomarkers and imaging study in subjects with angiographically documented coronary artery disease (CHD) to examine the effects of the novel lipoprotein-associated phospholipase A2 (Lp-PLA2) in Study Listed on ClinicalStudyDataRequest.com
SB681323/011 Completed An open label study to determine the excretion balance and pharmacokinetics of [14C]SB-681323, administered as a single dose of an oral solution to healthy adult male subjects.
SB-705498/008 Completed A single blind, placebo controlled, multi-centre study to investigate the pharmacokinetics, safety, tolerability and pharmacodynamics of the TRPV1 antagonist SB-705498 against the pain of acute migraine.
SB-714703/003 Completed An open, randomised, multi-centre dose-ranging phase II study to evaluate LAPDAP in combination with three different doses of artesunate.
SBM20001 Completed A single centre, randomised, double-blind, double-dummy, placebo-controlled, parallel group, pilot study to determine the efficacy and safety of 2mg and 4mg doses of Ventolin ™ (salbutamol) syrup for the treatment of cough associated with acute viral upper respiratory tract infection, during a 3 ...

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.